JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.

Setting

Order Through VWR & Receive a FREE Sample

Support: [email protected]

Track Your Order

VD/VDR

B2153 Alfacalcidol

Summary: Bone resorption inhibitor

insoluble in H2O; ≥20.05 mg/mL
B2141 Calcitriol

5 Citation

Summary: Active metabolite of vitamin D3

insoluble in H2O; ≥20.83 mg/mL
B2140 Calcifediol

Target: Vitamin D receptors (VDRs)

Summary: The major circulating form of vitamin D3, serving as a native vitamin D metabolite comparator (versus active vitamin D treatment groups) in animal models of vascular calcification and chronic kidney disease.

insoluble in H2O; ≥13.65 mg/mL
B2091 Doxercalciferol

1 Citation

Target: Vitamin D receptors (VDRs)

Summary: Vitamin D receptor activator

insoluble in H2O; ≥11.5 mg/mL
B2065 Vitamin D3

4 Citation

Summary: A fat-soluble steroid; combined with nicotine (VDN method) it induces vascular calcification rat models.

insoluble in H2O; ≥51.6 mg/mL
A3848 Tacalcitol

Summary: Promotes normal bone development by regulating calcium

Soluble in DMSO
A3814 Seocalcitol

Summary: Vitamin D receptor agonist

Soluble in DMSO
A3702 Paricalcitol

Summary: Analog of VD2 active form

≥50.7 mg/mL
A3588 MC 1046

Summary: Vitamin D3 analog

Soluble in DMSO
A3584 Maxacalcitol

Summary: Non-calcemic vitamin D3 analog and VDR ligand.

≥51 mg/mL